Cardiogenic shock is a state of reduced cardiac output leading to hypotension, pulmonary
congestion, and hypoperfusion of tissues and vital organs. Despite the advances in …

Biomarkers are useful for diagnosis, disease monitoring and risk stratification in
cardiovascular disease. Cardiogenic shock (CS) is a medical emergency caused by a …

Purpose To evaluate the association between the neutrophil-to-lymphocyte ratio (NLR) and
mortality across the cardiogenic shock (CS) severity spectrum, defined using the Society of …

In The Lancet Respiratory Medicine, Andrea Alemany and colleagues1 report the results of
CONV-ERT, a multicentre, double-blind, randomised controlled trial (RCT), administering …

OBJECTIVES: Mixed cardiogenic-septic shock is common and associated with high
mortality. There are limited contemporary data on concomitant sepsis in acute myocardial …

Background Shock increases mortality in the critically ill and the mainstay of therapy is the
administration of vasopressor agents to achieve hemodynamic targets. In the past, studies …

Acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) is a life-
threatening condition frequently encountered in patients with multivessel coronary artery …

Cardiogenic shock (CS) is the final common pathway of impaired cardiovascular
performance that results in ineffective forward cardiac output producing clinical and …

Background Systemic inflammatory response syndrome (SIRS) is a systemic insult that has
been described with many interventional cardiac procedures. The outcomes of patients …

Objective The management of cardiogenic shock (CS) in the elderly remains a major clinical
challenge. Existing clinical prediction models have not performed well in assessing the …